Safe Selection of Genetically Manipulated Human Primary Keratinocytes with Very High Growth Potential Using CD24
August 2007
in “
Molecular Therapy
”
Studysummary This study found that using ectopic expression of CD24 is a promising approach for selecting genetically modified human epidermal stem cells for safe cutaneous gene therapy in cancer-prone conditions.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer